Ph1 Marinol Interaction Study - Part 1 - 1

Stopped early · Phase 1

Conditions studied: Marijuana Dependence

In brief

The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant interactions before conducting outpatient studies.

Key facts

Study ID

NCT00438139

Run by

National Institute on Drug Abuse (NIDA)

People needed

6

Starts

2007-03-01

Expected to finish

2007-03-01

Last updated by the study team

2017-01-16

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be between the ages of 18 to 45 years of age
• Must be in good general health
• Must meet DSM-IV criteria for marijuana dependence and are non- treatment seekers at the time of study
• Must be able to provide written informed consent
• Must be able to provide 1 marijuana positive urine specimen (> 50 ng/mL) within the 28-day screening period
• If female and of child bearing potential, must agree to use birth control.

You may not qualify if…

• Please contact site for more information.

Where it is running

• Uniformed Services University of Health Science — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.